English  |  正體中文  |  简体中文  |  Items with full text/Total items : 94286/110023 (86%)
Visitors : 21658609      Online Users : 436
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/8239


    Title: Mechanisms of and obstacles to iron cardiomyopathy in thalassemia
    Authors: Peng, CT (Peng, Ching-Tien);Chang, JS (Chang, Jeng-Sheng);Wu, KH (Wu, Kang-Hsi);Tsai, CH (Tsai, Chang-Hai);Lin, HS (Lin, Huan-Sheng)
    Contributors: Department of Biotechnology
    Keywords: beta-thalassemia;iron cardiomyopathy;iron cardiotoxicity;cardioprotective chelation therapy;mechanism;review
    Date: 2008-05
    Issue Date: 2010-03-26 02:29:16 (UTC+0)
    Publisher: Asia University
    Abstract: Thalassemia is anemia of variable severity, arising from mutations of genes encoding the hemoglobin alpha and beta chains. Severe thalassemia is associated with iron overload, tissue lesions, and high risk for cardiovascular complications, and iron-mediated cardiomyopathy is the main cause of death in this condition. Thalassemia major (TM) patients exhibit cardiovascular abnormalities consistent with chronic anemia; these include enlargement of the ventricular chambers, increased cardiac output, and reduced total vascular resistance. Cardiac iron overload in TM patients due to long-term transfusion can cause further chamber dilation, decreased contractility, and arrhythmia. Paradoxically, many such patients remain asymptomatic until decompensation occurs. For decades, magnetic resonance imaging and echocardiography have been performed to detect advanced cardiac dysfunction; however, reliable evaluation tools for the early detection of cardiac abnormalities are currently in demand. This article reviews the mechanisms underlying the development of heart disease in thalassemia and strategies for therapeutic intervention in TM patients with congestive heart failure.
    Relation: FRONTIERS IN BIOSCIENCE�1. 3:5975-5987
    Appears in Collections:[生物科技學系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    134.docx0KbUnknown242View/Open
    310904400-8239.doc34KbMicrosoft Word168View/Open


    All items in ASIAIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback